

PTSF67 – Psilocybin, Power, and Patents
Jul 9, 2021
This podcast discusses a recent psilocybin study for depression, the DEA's stance on medical psilocybin, challenges of drug policy reform, historical context of patents and indigenous practices, self-identity through psychedelics, interactions between psilocybin and antidepressants, and the importance of therapist preparedness for psychedelic therapy.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7
Introduction
00:00 • 3min
Transitioning to the Psychedelic Space
03:09 • 20min
Exploring DEA's Stance on Psilocybin and Drug Policy Reform
23:19 • 36min
Exploring the Intersection of History, Science, and Cultural Practices
58:52 • 15min
Exploring Self-Identity and the Interaction of Psychedelics with Antidepressants
01:13:23 • 4min
Exploring Interactions Between Psilocybin & Antidepressants: Harm Reduction and Patent Considerations
01:17:47 • 3min
Closing Remarks on Psychedelic Education and Therapist Preparedness
01:20:53 • 3min